Piedmont Heart lands Kandzari and Dean, expands service
The Piedmont Heart Institute (PHI) has hired two cardiologists, David Dean, MD, and David Kandzari, MD, to help expand its cardiovascular care unit.
Dean, a cardiothoracic, heart transplant and ventricular assist device surgeon, previously worked at the Allegheny General Hospital in Pittsburgh, and will initiate PHI’s heart transplant program and expand its Hospital Transplant Institute.
Dean also serves on the heart review board of the Organ Procurement and Transplantation Network and United Network for Organ Sharing.
Kandzari, an interventional cardiologist and former professor at Duke University’s Cardiovascular Research Institute in Durham, N.C., will provide patient care and research opportunities to the Atlanta-based PHI.
Previously, Kandzari was chief medical officer at Cordis, a Johnson & Johnson company, an ad hoc medical reviewer to the FDA and a committee member of the FDA’s Circulatory Systems Device panel.
The two new additions will move PHI from a tertiary care center to a quaternary cardiovascular care center and expand its research program and patient care capabilities, according to William D. Knopf, MD, chief operating officer of PHI.
Dean, a cardiothoracic, heart transplant and ventricular assist device surgeon, previously worked at the Allegheny General Hospital in Pittsburgh, and will initiate PHI’s heart transplant program and expand its Hospital Transplant Institute.
Dean also serves on the heart review board of the Organ Procurement and Transplantation Network and United Network for Organ Sharing.
Kandzari, an interventional cardiologist and former professor at Duke University’s Cardiovascular Research Institute in Durham, N.C., will provide patient care and research opportunities to the Atlanta-based PHI.
Previously, Kandzari was chief medical officer at Cordis, a Johnson & Johnson company, an ad hoc medical reviewer to the FDA and a committee member of the FDA’s Circulatory Systems Device panel.
The two new additions will move PHI from a tertiary care center to a quaternary cardiovascular care center and expand its research program and patient care capabilities, according to William D. Knopf, MD, chief operating officer of PHI.